Compare
Centene Corp vs Elevance Health, Inc. vs Cigna Group vs Humana Inc
| Latest fiscal year | Centene Corp CNC | Elevance Health, Inc. ELV | Cigna Group CI | Humana Inc HUM |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $194.78B | $199.12B | $274.90B | $129.66B |
| Revenue growth (YoY) | +19.4% | +12.5% | +11.2% | +10.1% |
| Gross margin | 7.3% | n/a | n/a | n/a |
| Operating margin | -3.9% | 3.6% | 3.3% | 2.1% |
| Net margin | -3.4% | 2.8% | 2.3% | 0.9% |
| Net income | -$6.67B | $5.66B | $6.29B | $1.19B |
| EPS (Diluted) | -$13.53 | $25.21 | $22.18 | $9.84 |
| Operating cash flow | $5.09B | $4.29B | $9.60B | $921.00M |
| Free cash flow | $4.32B | $3.17B | n/a | $375.00M |
| Cash & equivalents | $17.89B | $9.49B | $7.68B | $4.20B |
| Total assets | $76.75B | $121.49B | $157.92B | $48.91B |
| Total liabilities | $56.69B | $77.47B | $116.05B | $31.17B |
| Shareholders' equity | $20.03B | $43.88B | $41.87B | $17.66B |
| Return on year-end equity | -33.3% | 12.9% | 15.0% | 6.7% |
| Shares outstanding | 491.76M | 220.72M | 263.46M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Centene Corp | Elevance Health, Inc. | Cigna Group | Humana Inc |
|---|---|---|---|---|
| Latest | $194.78B Ended 2025-12-31 | $199.12B Ended 2025-12-31 | $274.90B Ended 2025-12-31 | $129.66B Ended 2025-12-31 |
| 1 year earlier | $163.07B Ended 2024-12-31 | $177.01B Ended 2024-12-31 | $247.12B Ended 2024-12-31 | $117.76B Ended 2024-12-31 |
| 2 years earlier | $154.00B Ended 2023-12-31 | $171.34B Ended 2023-12-31 | $195.26B Ended 2023-12-31 | $106.37B Ended 2023-12-31 |
| 3 years earlier | $144.55B Ended 2022-12-31 | $156.59B Ended 2022-12-31 | $180.52B Ended 2022-12-31 | $92.87B Ended 2022-12-31 |
| 4 years earlier | $125.98B Ended 2021-12-31 | $138.64B Ended 2021-12-31 | $174.07B Ended 2021-12-31 | $83.06B Ended 2021-12-31 |